Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Filter News
Area of Research
News Topics
Media Contacts
For the first time since 2011, scientific users of Oak Ridge National Laboratory’s High Flux Isotope Reactor were able to take advantage of a seventh cycle, allowing for 25 extra days of neutron production and available time for new experiments on HFIR’s 12 beam lines in fiscal ye...
The theories recognized with this year’s Nobel Prize in Physics underpin research ongoing at the Department of Energy’s Oak Ridge National Laboratory, where scientists are using neutrons as a probe to seek new materials with extraordinary properties for applications such as next-generation electronics, superconductors, and quantum computing.
The first of its kind superconducting linear particle accelerator (LINAC) built for the Spallation Neutron Source (SNS) at the Department of Energy’s Oak Ridge National Laboratory is now celebrating 10 years of successful operations.
The world-leading machine, which took 7 years...
In August, the High Flux Isotope Reactor and the Spallation Neutron Source—both U.S. Department of Energy Office of Science User Facilities at DOE’s Oak Ridge National Laboratory—reached a milestone with the arrival of Irina Nesmelova, the facilities’ 20,000th user.
“We ...
Theory and experiment push each other to expand the frontiers of physics. Now, the Neutron Sciences Directorate at the Department of Energy’s Oak Ridge National Laboratory has both.
Cristian Batista, a theoretical condensed matter physicist with a joint appointment at ORNL and th...
A new study by a multi-institutional team, led by researchers from Brookhaven National Laboratory and Stony Brook University, has revealed exotic magnetic properties in a rare-earth based intermetallic compound. Similar studies suggest a better understanding of those types of behavio...
A team led by the Department of Energy’s Oak Ridge National Laboratory used neutron analysis to better understand a protein implicated in the replication of HIV, the retrovirus that causes AIDS. The enzyme, known as HIV-1 protease, is a key drug target for HIV and AIDS therapies. &nbs...